+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infection Drug"

Oral Voriconazole Market - Global Forecast 2025-2030 - Product Thumbnail Image

Oral Voriconazole Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
Quinacrine Market - Global Forecast to 2030 - Product Thumbnail Image

Quinacrine Market - Global Forecast to 2030

  • Report
  • August 2025
  • 188 Pages
  • Global
From
From
Pseudomonas Aeruginosa Infection Treatment Market - Product Thumbnail Image

Pseudomonas Aeruginosa Infection Treatment Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
From
From
From
Complicated Urinary Tract Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Complicated Urinary Tract Infections - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
Uncomplicated Urinary Tract Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Uncomplicated Urinary Tract Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 60 Pages
  • Global
From
From
Loading Indicator

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs. Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more